Integrin-FAK-CDC42-PP1A signaling gnaws at YAP/TAZ activity to control incisor stem cells

BioEssays

Volumn 39, Issue 10, 2017, Pages

  Hicks Berthet, Julia ^a   Varelas, Xaralabos ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

stem cells; YAP TAZ

Indexed keywords

FAK PROTEIN; INTEGRIN; PP1A PROTEIN; PROTEIN; PROTEIN CDC42; UNCLASSIFIED DRUG; YES ASSOCIATED PROTEIN; SIGNAL PEPTIDE; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TRANSCRIPTION FACTOR;

CELL POLARITY; EPITHELIUM; EXTRACELLULAR MATRIX; MTOR SIGNALING; NONHUMAN; PROTEIN DEPHOSPHORYLATION; REVIEW; SIGNAL TRANSDUCTION; STEM CELL; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION; ANIMAL; CYTOLOGY; HUMAN; INCISOR; METABOLISM; MOUSE;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CDC42 GTP-BINDING PROTEIN; HUMANS; INCISOR; INTEGRINS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; SIGNAL TRANSDUCTION; STEM CELLS; TRANSCRIPTION FACTORS;

EID: 85029217822     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201700116     Document Type: Review

References (93)

1. Hu JK, Du W, Shelton SJ, Oldham MC, et al. 2017. An FAK-YAP-mTOR signaling axis regulates stem cell-based tissue renewal in mice. Cell Stem Cell 21: 91–106.e6.
2. Huang J, Wu S, Barrera J, Matthews K, et al. 2005. The Hippo signaling pathway coordinately regulates cell proliferation and apoptosis by inactivating Yorkie, the Drosophila Homolog of YAP. Cell 122: 421–34.
3. Jia J, Zhang W, Wang B, Trinko R, et al. 2003. The Drosophila Ste20 family kinase dMST functions as a tumor suppressor by restricting cell proliferation and promoting apoptosis. Genes Dev 17: 2514–9.
4. Justice RW, Zilian O, Woods DF, Noll M, et al. 1995. The Drosophila tumor suppressor gene warts encodes a homolog of human myotonic dystrophy kinase and is required for the control of cell shape and proliferation. Genes Dev 9: 534–46.
5. Pantalacci S, Tapon N, Leopold P. 2003. The Salvador partner Hippo promotes apoptosis and cell-cycle exit in Drosophila. Nat Cell Biol 5: 921–7.
6. Tapon N, Harvey KF, Bell DW, Wahrer DC, et al. 2002. Salvador Promotes both cell cycle exit and apoptosis in Drosophila and is mutated in human cancer cell lines. Cell 110: 467–78.
7. Udan RS, Kango-Singh M, Nolo R, Tao C, et al. 2003. Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway. Nat Cell Biol 5: 914–20.
8. Wu S, Huang J, Dong J, Pan D. 2003. Hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts. Cell 114: 445–56.
9. Yu FX, Zhao B, Guan KL. 2015. Hippo pathway in organ size control, tissue homeostasis, and cancer. Cell 163: 811–28.
10. Zhao B, Wei X, Li W, Udan RS, et al. 2007. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 21: 2747–61.
11. Hao Y, Chun A, Cheung K, Rashidi B, et al. 2008. Tumor suppressor LATS1 is a negative regulator of oncogene YAP. J Biol Chem 283: 5496–509.
12. Zhao B, Wei X, Li W, Udan RS, et al. 2007. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control. Genes Dev 21: 2747–61.
13. Dong J, Feldmann G, Huang J, Wu S, et al. 2007. Elucidation of a universal size-control mechanism in Drosophila and mammals. Cell 130: 1120–33.
14. Kanai F, Marignani PA, Sarbassova D, Yagi R, et al. 2000. TAZ: a novel transcriptional co-activator regulated by interactions with 14-3-3 and PDZ domain proteins. EMBO J 19: 6778–91.
15. Zhao B, Li L, Tumaneng K, Wang CY, et al. 2010. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(beta-TRCP). Genes Dev 24: 72–85.
16. Liu CY, Zha ZY, Zhou X, Zhang H, et al. 2010. The hippo tumor pathway promotes TAZ degradation by phosphorylating a phosphodegron and recruiting the SCF{beta}-TrCP E3 ligase. J Biol Chem 285: 37159–69.
17. Mo JS, Meng Z, Kim YC, Park HW, et al. 2015. Cellular energy stress induces AMPK-mediated regulation of YAP and the Hippo pathway. Nat Cell Biol 17: 500–10.
18. Hong AW, Meng Z, Yuan HX, Plouffe SW, et al. 2017. Osmotic stress-induced phosphorylation by NLK at Ser128 activates YAP. EMBO Rep 18: 72–86.
19. Moon S, Kim W, Kim S, Kim Y, et al. 2017. Phosphorylation by NLK inhibits YAP-14-3-3-interactions and induces its nuclear localization. EMBO Rep 18: 61–71.
20. Huang W, Lv X, Liu C, Zha Z, et al. 2012. The N-terminal phosphodegron targets TAZ/WWTR1 protein for SCFbeta-TrCP-dependent degradation in response to phosphatidylinositol 3-kinase inhibition. J Biol Chem 287: 26245–53.
21. Saxton RA, Sabatini DM. 2017. MTOR signaling in growth, metabolism, and disease. Cell 169: 361–71.
22. Chen L, Chan SW, Zhang X, Walsh M, et al. 2010. Structural basis of YAP recognition by TEAD4 in the hippo pathway. Genes Dev 24: 290–300.
23. Li Z, Zhao B, Wang P, Chen F, et al. 2010. Structural insights into the YAP and TEAD complex. Genes Dev 24: 235–40.
24. Zhao B, Ye X, Yu J, Li L, et al. 2008. TEAD mediates YAP-dependent gene induction and growth control. Genes Dev 22: 1962–71.
25. Mauviel A, Nallet-Staub F, Varelas X. 2012. Integrating developmental signals: a Hippo in the (path)way. Oncogene 31: 1743–56.
26. Beyer TA, Weiss A, Khomchuk Y, Huang K, et al. 2013. Switch enhancers interpret TGF-beta and hippo signaling to control cell fate in human embryonic stem cells. Cell Rep 5: 1611–24.
27. Galli GG, Carrara M, Yuan WC, Valdes-Quezada C, et al. 2015. YAP drives growth by controlling transcriptional pause release from dynamic enhancers. Mol Cell 60: 328–37.
28. Stein C, Bardet AF, Roma G, Bergling S, et al. 2015. YAP1 exerts its transcriptional control via TEAD-mediated activation of enhancers. PLoS Genet 11: e1005465.
29. Zanconato F, Forcato M, Battilana G, Azzolin L, et al. 2015. Genome-wide association between YAP/TAZ/TEAD and AP-1 at enhancers drives oncogenic growth. Nat Cell Biol 17: 1218–27.
30. Fujii M, Toyoda T, Nakanishi H, Yatabe Y, et al. 2012. TGF-beta synergizes with defects in the Hippo pathway to stimulate human malignant mesothelioma growth. J Exp Med 209: 479–94.
31. Strano S, Monti O, Pediconi N, Baccarini A, et al. 2005. The transcriptional coactivator Yes-associated protein drives p73 gene-target specificity in response to DNA Damage. Mol Cell 18: 447–59.
32. Skibinski A, Breindel JL, Prat A, Galvan P, et al. 2014. The Hippo transducer TAZ interacts with the SWI/SNF complex to regulate breast epithelial lineage commitment. Cell reports 6: 1059–72.
33. Rashidian J, Le Scolan E, Ji X, Zhu Q, et al. 2015. Ski regulates Hippo and TAZ signaling to suppress breast cancer progression. Sci Signal 8: ra14.
34. Zhao R, Fallon TR, Saladi SV, Pardo-Saganta A, et al. 2014. Yap tunes airway epithelial size and architecture by regulating the identity, maintenance, and self-renewal of stem cells. Dev Cell 30: 151–65.
35. Imajo M, Ebisuya M, Nishida E. 2015. Dual role of YAP and TAZ in renewal of the intestinal epithelium. Nat Cell Biol 17: 7–19.
36. Varelas X, Sakuma R, Samavarchi-Tehrani P, Peerani R, et al. 2008. TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal. Nat Cell Biol 10: 837–48.
37. Heallen T, Zhang M, Wang J, Bonilla-Claudio M, et al. 2011. Hippo pathway inhibits Wnt signaling to restrain cardiomyocyte proliferation and heart size. Science 332: 458–61.
38. Liu X, Li H, Rajurkar M, Li Q, et al. 2016. Tead and AP1 coordinate transcription and motility. Cell Rep 14: 1169–80.
39. Varelas X. 2014. The Hippo pathway effectors TAZ and YAP in development, homeostasis and disease. Development 141: 1614–26.
40. Mahoney JE, Mori M, Szymaniak AD, Varelas X, et al. 2014. The hippo pathway effector Yap controls patterning and differentiation of airway epithelial progenitors. Dev Cell 30: 137–50.
41. Szymaniak AD, Mi R, McCarthy SE, Gower AC, et al. 2017. The Hippo pathway effector YAP is an essential regulator of ductal progenitor patterning in the mouse submandibular gland. Elife 6: e23499.
42. Gao T, Zhou D, Yang C, Singh T, et al. 2013. Hippo signaling regulates differentiation and maintenance in the exocrine pancreas. Gastroenterology 144: 1543–53, 53 e1.
43. George NM, Day CE, Boerner BP, Johnson RL, et al. 2012. Hippo signaling regulates pancreas development through inactivation of Yap. Mol Cell Biol 32: 5116–28.
44. Lee JH, Kim TS, Yang TH, Koo BK, et al. 2008. A crucial role of WW45 in developing epithelial tissues in the mouse. EMBO J 27: 1231–42.
45. Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, et al. 2011. Yap1 acts downstream of alpha-catenin to control epidermal proliferation. Cell 144: 782–95.
46. Panciera T, Azzolin L, Fujimura A, Di Biagio D, et al. 2016. Induction of expandable tissue-specific stem/progenitor cells through transient expression of YAP/TAZ. Cell Stem Cell 19: 725–37.
47. Finch-Edmondson ML, Strauss RP, Passman AM, Sudol M, et al. 2015. TAZ protein accumulation is negatively regulated by YAP abundance in mammalian cells. J Biol Chem 290: 27928–38.
48. Elbediwy A, Vincent-Mistiaen ZI, Spencer-Dene B, Stone RK, et al. 2016. Integrin signalling regulates YAP and TAZ to control skin homeostasis. Development 143: 1674–87.
49. Zhang H, Pasolli HA, Fuchs E. 2011. Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin. Proc Natl Acad Sci USA 108: 2270–5.
50. Schlegelmilch K, Mohseni M, Kirak O, Pruszak J, et al. 2011. Yap1 acts downstream of α-catenin to control epidermal proliferation. Cell 144: 782–95.
51. Totaro A, Castellan M, Battilana G, Zanconato F, et al. 2017. YAP/TAZ link cell mechanics to Notch signalling to control epidermal stem cell fate. Nat Commun 8: 15206.
52. Walko G, Woodhouse S, Pisco AO, Rognoni E, et al. 2017. A genome-wide screen identifies YAP/WBP2 interplay conferring growth advantage on human epidermal stem cells. Nat Commun 8: 14744.
53. Gregorieff A, Liu Y, Inanlou MR, Khomchuk Y, et al. 2015. Yap-dependent reprogramming of Lgr5(+) stem cells drives intestinal regeneration and cancer. Nature 526: 715–8.
54. Barry ER, Morikawa T, Butler BL, Shrestha K, et al. 2013. Restriction of intestinal stem cell expansion and the regenerative response by YAP. Nature 493: 106–10.
55. Cai J, Zhang N, Zheng Y, de Wilde RF, et al. 2010. The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program. Genes Dev 24: 2383–8.
56. Makita R, Uchijima Y, Nishiyama K, Amano T, et al. 2008. Multiple renal cysts, urinary concentration defects, and pulmonary emphysematous changes in mice lacking TAZ. Am J Physiol Renal Physiol 294: F542–53.
57. Mitani A, Nagase T, Fukuchi K, Aburatani H, et al. 2009. Transcriptional coactivator with PDZ-binding motif is essential for normal alveolarization in mice. Am J Respir Crit Care Med 180: 326–38.
58. Tumaneng K, Schlegelmilch K, Russell RC, Yimlamai D, et al. 2012. YAP mediates crosstalk between the Hippo and PI(3)K-TOR pathways by suppressing PTEN via miR-29. Nat Cell Biol 14: 1322–9.
59. Hansen CG, Ng YL, Lam WL, Plouffe SW, et al. 2015. The Hippo pathway effectors YAP and TAZ promote cell growth by modulating amino acid signaling to mTORC1. Cell Res 25: 1299–313.
60. Kim M, Kim T, Johnson Randy L, Lim D-S. 2015. Transcriptional co-repressor function of the hippo pathway transducers YAP and TAZ. Cell Rep 11: 270–82.
61. Castilho RM, Squarize CH, Chodosh LA, Williams BO, et al. 2009. MTOR mediates wnt-induced epidermal stem cell exhaustion and aging. Cell Stem Cell 5: 279–89.
62. Iglesias-Bartolome R, Patel V, Cotrim A, Leelahavanichkul K, et al. 2012. MTOR inhibition prevents epithelial stem cell senescence and protects from radiation-induced mucositis. Cell Stem Cell 11: 401–14.
63. Chen C, Liu Y, Liu R, Ikenoue T, et al. 2008. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J Exp Med 205: 2397–408.
64. Chung C, Kim T, Kim M, Kim M, et al. 2013. Hippo-Foxa2 signaling pathway plays a role in peripheral lung maturation and surfactant homeostasis. Proc Natl Acad Sci USA 110: 7732–7.
65. Lange AW, Sridharan A, Xu Y, Stripp BR, et al. 2014. Hippo/Yap signaling controls epithelial progenitor cell proliferation and differentiation in the embryonic and adult lung. J Mol Cell Biol 7: 35–47.
66. Zhou D, Zhang Y, Wu H, Barry E, et al. 2011. Mst1 and Mst2 protein kinases restrain intestinal stem cell proliferation and colonic tumorigenesis by inhibition of Yes-associated protein (Yap) overabundance. Proc Natl Acad Sci USA 108: E1312–20.
67. Lee KP, Lee JH, Kim TS, Kim TH, et al. 2010. The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis. Proc Natl Acad Sci USA 107: 8248–53.
68. Lu L, Li Y, Kim SM, Bossuyt W, et al. 2010. Hippo signaling is a potent in vivo growth and tumor suppressor pathway in the mammalian liver. Proc Natl Acad Sci USA 107: 1437–42.
69. Song H, Mak KK, Topol L, Yun K, et al. 2010. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc Natl Acad Sci USA 107: 1431–6.
70. Zhou D, Conrad C, Xia F, Park JS, et al. 2009. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 16: 425–38.
71. Meng Z, Moroishi T, Mottier-Pavie V, Plouffe SW, et al. 2015. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway. Nat Commun 6: 8357.
72. Zheng Y, Wang W, Liu B, Deng H, et al. 2015. Identification of happyhour/MAP4K as alternative hpo/Mst-like kinases in the hippo kinase cascade. Dev Cell 34: 642–55.
73. Liu C-Y, Lv X, Li T, Xu Y, et al. 2011. PP1 cooperates with ASPP2 to dephosphorylate and activate TAZ. J Biol Chem 286: 5558–66.
74. Couzens AL, Knight JDR, Kean MJ, Teo G, et al. 2013. Protein interaction network of the mammalian hippo pathway reveals mechanisms of kinase-phosphatase interactions. Sci Signal 6: rs15-rs.
75. Lechler T, Fuchs E. 2005. Asymmetric cell divisions promote stratification and differentiation of mammalian skin. Nature 437: 275–80.
76. Li P, Silvis MR, Honaker Y, Lien WH, et al. 2016. AlphaE-catenin inhibits a Src-YAP1 oncogenic module that couples tyrosine kinases and the effector of Hippo signaling pathway. Genes Dev 30: 798–811.
77. Kim NG, Gumbiner BM. 2015. Adhesion to fibronectin regulates Hippo signaling via the FAK-Src-PI3K pathway. J Cell Biol 210: 503–15.
78. Imada S, Murata Y, Kotani T, Hatano M, et al. 2016. Role of Src family kinases in regulation of intestinal epithelial homeostasis. Mol Cell Biol 36: 2811–2823. https://doi.org/10.1128/MCB.00311-16
79. Taniguchi K, Wu L-W, Grivennikov SI, de Jong PR, et al. 2015. A gp130-Src-YAP module links inflammation to epithelial regeneration. Nature 519: 57–62.
80. Aragona M, Panciera T, Manfrin A, Giulitti S, et al. 2013. A mechanical checkpoint controls multicellular growth through YAP/TAZ regulation by actin-processing factors. Cell 154: 1047–59.
81. Dupont S, Morsut L, Aragona M, Enzo E, et al. 2011. Role of YAP/TAZ in mechanotransduction. Nature 474: 179–83.
82. Chakraborty S, Njah K, Pobbati AV, Lim YB, et al. 2017. Agrin as a mechanotransduction signal regulating YAP through the hippo pathway. Cell Rep 18: 2464–79.
83. Nardone G, Oliver-De La Cruz J, Vrbsky J, Martini C, et al. 2017. YAP regulates cell mechanics by controlling focal adhesion assembly. Nat Commun 8: 15321.
84. Fan R, Kim N-G, Gumbiner BM. 2013. Regulation of Hippo pathway by mitogenic growth factors via phosphoinositide 3-kinase and phosphoinositide-dependent kinase-1. Proc Natl Acad Sci USA 110: 2569–74.
85. Iglesias-Bartolome R, Torres D, Marone R, Feng X, et al. 2015. Inactivation of a Galpha(s)-PKA tumour suppressor pathway in skin stem cells initiates basal-cell carcinogenesis. Nat Cell Biol 17: 793–803.
86. Whiteman EL, Fan S, Harder JL, Walton KD, et al. 2014. Crumbs3 is essential for proper epithelial development and viability. Mol Cell Biol 34: 43–56.
87. Szymaniak AD, Mahoney JE, Cardoso WV, Varelas X. 2015. Crumbs3-mediated polarity directs airway epithelial cell fate through the hippo pathway effector yap. Dev Cell 34: 283–96.
88. Varelas X, Samavarchi-Tehrani P, Narimatsu M, Weiss A, et al. 2010. The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-beta-SMAD pathway. Dev Cell 19: 831–44.
89. Fletcher GC, Elbediwy A, Khanal I, Ribeiro PS, et al. 2015. The Spectrin cytoskeleton regulates the Hippo signalling pathway. EMBO J 34: 940–54.
90. Medina E, Williams J, Klipfell E, Zarnescu D, et al. 2002. Crumbs interacts with moesin and beta(Heavy)-spectrin in the apical membrane skeleton of Drosophila. J Cell Biol 158: 941–51.
91. Fletcher GC, Elbediwy A, Khanal I, Ribeiro PS, et al. 2015. The Spectrin cytoskeleton regulates the Hippo signalling pathway. EMBO J 34: 940–54.
92. Silvis MR, Kreger BT, Lien WH, Klezovitch O, et al. 2011. Alpha-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1. Sci Signal 4: ra33.
93. Li CY, Hu J, Lu H, Lan J, et al. 2016. AlphaE-catenin inhibits YAP/TAZ activity to regulate signalling centre formation during tooth development. Nat Commun 7: 12133.